Imunon, Inc.
Imunon, Inc. (IMNN) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · IMNN · as of Jun 9, 2026
Key Statistics
Explore Imunon, Inc. Data
imnn stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 4 · Buy rate: 75.0%
The IMNN analyst consensus is Buy, based on ratings from 4 Wall Street analysts over the past 3 months. The average 12-month price target is $10.00, representing +397.51% upside from the current price of $2.01.
Competitors & Peers
imnn competitorsIMNN
AEON
BOLT
CING
CLRB
COCPStock Performance
Full HistoryAbout Imunon, Inc.
Imunon, Inc. is a clinical-stage biotechnology company dedicated to the development and commercialization of DNA-based immunotherapies, vaccines, and directed chemotherapies. The company's pipeline fe…
what is imunon, inc. · imnn stock overview · imunon, inc. company profile · who is imunon, inc. ceo · imnn NASDAQ · imunon, inc. headquarters · imunon, inc. business segments
About Stock Overview & Key Data
Imunon, Inc. (IMNN) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Mar 1, 1999. As of the latest trading session, IMNN stock price is $2.01, with a market capitalization of $5.1M. The stock has returned -89.92% over the past 12 months and -47.24% year-to-date.
According to 4 Wall Street analysts, the consensus rating for Imunon, Inc. stock is Buy, with an average 12-month price target of $10.00. In fiscal year 2025, Imunon, Inc. reported revenue of — and net income of -$14.5M. For detailed data — including Imunon, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Imunon, Inc. (IMNN) stock price is $2.01. The stock is traded on NASDAQ under the ticker symbol IMNN. The 52-week range is $1.96 – $27.65.